Strong Buy
Average AnalystStrong Buy
Top AnalystNeutral
Stock Target AdvisorStrong Buy
Average UserUSD 34.19
0.00 (0.00)%
USD 3.52B
0.39M
USD 56.63(+65.62%)
Symbol | Name | Exchange | AGIO's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
L&G Pharma Breakthrough U.. | XETRA | 3.71 % | 0.49 % | 0.00 (0.00%) | USD0.02B |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median revenue growth in the previous 5 years compared to its sector